|
Originally published In Press as doi:10.1074/jbc.M207077200 on August 16, 2002
J. Biol. Chem., Vol. 277, Issue 42, 40005-40011, October 18, 2002
A Nonpermeant Biotin Derivative Gains Access to the
Parasitophorous Vacuole in Plasmodium falciparum-infected
Erythrocytes Permeabilized with Streptolysin O*
Julius
Nyalwidhe §,
Stefan
Baumeister ,
Alan R.
Hibbs¶ ,
Sallah
Tawill **,
Janni
Papakrivos ,
Uwe
Völker , and
Klaus
Lingelbach 
From the FB Biologie, Philipps-Universität
Marburg, D-35032 Marburg, Germany and ¶ BIOCON, Ringwood East
VIC 3135, Australia
Received for publication, July 15, 2002, and in revised form, August 16, 2002
 |
ABSTRACT |
In its host erythrocyte, the malaria parasite
Plasmodium falciparum resides within a parasitophorous
vacuole, the membrane of which forms a barrier between the host cell
cytosol and the parasite surface. The vacuole is a unique compartment
because it contains specific proteins that are believed to be involved in cell biological functions essential for parasite survival. As a
prerequisite for the characterization of the vacuolar proteome, we have
developed an experimental approach that allows the selective biotinylation of soluble vacuolar proteins. This approach utilizes nonpermeant biotin derivatives that can be introduced into infected erythrocytes after selective permeabilization of the erythrocyte membrane with the pore-forming protein streptolysin O. The derivatives gain access to the vacuolar lumen but not to the parasite cytosol, thus
providing supportive evidence for the existence of nonselective pores
within the vacuolar membrane that have been postulated based on
electrophysiological studies. Soluble vacuolar proteins that are
biotin-labeled can be isolated by affinity chromatography using
streptavidin-agarose.
 |
INTRODUCTION |
Plasmodium falciparum, the causative agent of the most
severe form of malaria, invades human erythrocytes, where this
unicellular parasite develops within the so-called parasitophorous
vacuole (PV).1 The
parasitophorous vacuolar membrane (PVM) is formed during the process of
invasion, and it contains lipids from the erythrocyte plasma membrane
(1, 2) and, presumably, parasite-derived proteins and lipids (3). This
membrane presents a barrier between parasite and host cell cytosol,
although electrophysiological studies in Plasmodium-infected
erythrocytes suggest the existence of nonselective pores within the PVM
that allow passive bidirectional diffusion of small molecules (4, 5).
With respect to biogenesis and protein contents, the PV differs
significantly from endocytic vacuoles (6), with the most apparent
difference being the almost cytosolic pH of the vacuole (7, 8). In
recent years, many observations have indicated a number of cell
biologically relevant processes within the vacuole that are important
for parasite survival.
In the course of the infection, several parasite proteins are exported
into the erythrocyte, and some of these proteins, such as the members
of the PfEMP1 family, are key molecules involved in the
pathogenesis of malaria (9). For at least some exported proteins, the
PV is a transit compartment from which they are transported into the
host cell cytosol (10-12). Translocation across the vacuolar membrane
must be a selective process because other proteins are retained within
the PV (13, 14). Recently, it has been suggested that proteins destined
for the parasite apicoplast, a unique plastid-like intracellular
organelle of apicomplexan parasites, also may be trafficked via the PV
(15). Thus, the PV must contain a machinery involved in protein
sorting. Upon completion of parasite development and multiplication,
merozoites, the invasive stages, are released from the infected cell.
Release of merozoites from the PV can be prevented by treatment of
infected erythrocytes (IRBCs) with protease inhibitors (16). In
addition, evasion of merozoites is accompanied by a specific sequential cleavage of the major merozoite surface protein 1 that is essential for
the subsequent reinvasion of noninfected cells (17). These data suggest
a role of vacuolar proteases in the release of parasites from the
infected host cell. Collectively, the current observations underscore
the notion that the PV is a unique intracellular compartment critical
for parasite survival within the host cell and that it most likely
contains novel proteins of elementary functions.
The volume of the vacuole compared with the volumes of the parasite
cytosol and the erythrocyte cytosol, respectively, is very small.
Estimates based on morphological data suggest a 1:10,000 ratio of
vacuolar volume to erythrocyte cytosol in IRBCs infected with stages of
the parasite that have completed ~30 h of the 48-h intraerythrocytic
development (12). Cell fractionation experiments on IRBCs infected with
the same developmental stages show that more than 70% of the total
protein are erythrocyte cytosolic proteins, predominantly hemoglobin
(18). Therefore, the isolation of vacuolar proteins is difficult;
consequently, only a few vacuolar proteins have been identified thus
far. In this report, we describe a novel strategy for the
identification of vacuolar proteins as a prerequisite for a
comprehensive proteome analysis of this compartment.
 |
EXPERIMENTAL PROCEDURES |
Biotin derivatives sulfosuccinimidyl-2-(biotinamido)
ethyl-1-3dithiopropionate (sulfo-NHS-SS-biotin),
sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-LC-biotin),
and streptavidin (SAv)-conjugated agarose beads were obtained from
Pierce. L-[35S]Methionine was obtained from
Amersham Biosciences. Streptolysin O (SLO) was kindly provided by S. Bhakdi and prepared as described elsewhere (10). Polyclonal rabbit
antibodies directed against GBP, SERP, parasite aldolase, and PfBiP
have been described previously (12, 19). The mouse monoclonal antibody
to band 3, clone III-136, was obtained from Sigma. Secondary antibodies
against rabbit IgG conjugated to alkaline phosphatase or to horseradish
peroxidase were obtained from DAKO A/S. Cy2-conjugated goat anti-mouse
IgG, Cy5-conjugated goat anti-rabbit IgG, and Cy3-conjugated
streptavidin were from Jackson Immuno Research Laboratories, Inc.
Protein A-Sepharose beads were from Amersham Biosciences.
Parasite Cultures and Permeabilization of Infected
Erythrocytes--
Parasites of the P. falciparum FCBR
strain were cultivated in RPMI 1640 medium (Invitrogen) containing 10%
human plasma and erythrocytes of blood group A+ (Marburg
Blood Bank) under standard conditions (20). Trophozoite-infected erythrocytes (IRBCs) were enriched to a parasitemia of >90% by gel
floatation (21). For metabolic labeling of newly synthesized proteins,
enriched IRBCs were washed twice in methionine-free RPMI 1640 medium
and cultivated for 1 h in plasma-free, methionine-free RPMI
1640 medium, in the presence of 50 µCi ml 1
L-[35S]methionine. IRBCs were permeabilized
with SLO as described previously (10). Briefly, 2 × 108 IRBCs were incubated with 3-4 hemolytic units of SLO
in RPMI 1640 medium at room temperature for 6 min. Samples were
centrifuged at 10,000 × g for 15 s. The pellet
containing intact parasites, the vacuolar contents, and
membranes was washed with 200 µl of RPMI 1640 medium before
biotinylation. Complete removal of the erythrocyte hemoglobin was
monitored spectrophotometrically as described previously (10).
Biotin Labeling--
For the biotinylation of intact
erythrocytes, 108 parasitized or nonparasitized
erythrocytes were washed three times in PBS containing 0.6 mM CaCl2 and 1 mM
MgCl2, pH 7.6 (PBS2+), and then incubated in
PBS2+ containing 1 mg ml 1 sulfo-NHS-SS-biotin
for 30 min on ice. Cells were sedimented by centrifugation at
10,000 × g for 15 s at 4 °C. The supernatant was analyzed photometrically at 412 nm for the release of hemoglobin. To block and remove unbound biotin, cells were washed three times in
PBS2+ containing 100 mM glycine. For cleavage
of extracellularly exposed membrane proteins, an aliquot of the cells
was treated with 1 mg ml 1 trypsin for 15 min at 37 °C.
The protease was inactivated using soybean trypsin inhibitor at a
concentration of 1 mg ml 1 for 15 min on ice. Cells were
lysed by repeated freezing and thawing in water supplemented with a
protease inhibitor mixture containing antipain, chymostatin,
aprotinin, trypsin inhibitor, Na-EDTA, pepstatin, leupeptin, and
elastatinal, each at a concentration of 1 µg ml 1. A
membrane fraction and a fraction of soluble proteins were prepared by centrifugation.
For the biotinylation of internal parasite proteins and vacuolar
proteins, IRBCs permeabilized with SLO were washed with
PBS2+ and then resuspended in an optimal volume, routinely
800 µl, of distilled water containing the above-mentioned protease
inhibitors. Lysates were prepared by three cycles of freezing and
thawing. Soluble proteins contained in the supernatant after
centrifugation at 10,000 × g for 15 min were
biotin-labeled in PBS2+ containing 1 mg ml 1
sulfo-NHS-LC-biotin for 30 min at 4 °C with frequent shaking. The
solution was centrifuged at 3,000 × g using a
microconcentrator (Millipore Corp.) with a size exclusion of 5 kDa to
remove any free biotin. The sample was diluted with water containing
the protease inhibitors. This step was repeated twice.
For the labeling of soluble vacuolar proteins, permeabilized cells were
incubated with sulfo-NHS-LC-biotin as described above. The solution was
centrifuged at 4 °C at 1,300 × g for 5 min, and the
sediment of parasite-containing vacuoles was washed three times in 100 mM glycine in PBS2+ to block the unreacted
biotin derivative. After a final wash in PBS2+, cells were
lysed and processed as above.
Affinity Purification of Biotin-labeled
Proteins--
Biotin-labeled proteins from 2 × 108
IRBCs were incubated with streptavidin-conjugated agarose beads at
4 °C for 2 h under constant shaking. The beads were sedimented
by centrifugation at 10,000 × g for 15 s. The
supernatant was collected and stored at 20 °C until further use.
Beads were washed sequentially in buffer A (10 mM Tris-HCl,
pH 7.5, 0.2% Nonidet P-40, 2 mM EDTA, and 150 mM NaCl), buffer B (10 mM Tris-HCl, pH 7.5, 0.2% Nonidet P-40, 2 mM EDTA, and 500 mM
NaCl), buffer C (10 mM Tris-HCl, pH 7.5), and, finally,
PBS2+. The beads were then washed with 10 mM
HEPES buffer, pH 7.4, containing 20 mM MgCl2
and 5 mM ATP. Bound proteins were eluted by boiling the
beads in SDS-PAGE sample buffer before analysis.
Immunoprecipitation--
The marker proteins SERP and GBP were
precipitated from lysates of IRBCs as follows. After permeabilization
of IRBCs and complete removal of the erythrocyte cytosol,
parasite-containing vacuoles were lysed osmotically. Soluble proteins
in a volume of 100 µl, corresponding to 2 × 107
IRBCs, were diluted with 400 µl of distilled water and 500 µl of
solubilization buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, and 4 µg ml 1
phenylmethylsulfonyl fluoride. The respective antisera were added, and
the mixture was incubated at room temperature for 30 min. Subsequently,
15 µl of protein A-Sepharose beads were added and incubated for
1 h at 4 °C. The beads were sedimented by centrifugation, and
the supernatant was collected. Proteins were precipitated from the
supernatant with 10% trichloroacetic acid on ice for 10 min. The
samples were centrifuged at 4 °C, and the precipitate was washed
with ice-cold acetone and dissolved in SDS-PAGE sample buffer. The
protein A-Sepharose beads were washed sequentially with buffers A, B,
and C and PBS2+ as described above, and bound proteins were
eluted by boiling the beads in SDS-PAGE sample buffer.
Gel Electrophoresis--
Routinely, proteins were dissolved in
SDS sample buffer and separated on 10% or 12% gels under
reducing conditions. When proteins were labeled with the
cleavable biotin derivative sulfo-NHS-SS-biotin, separation was on
5-20% gradient gels under nonreducing conditions. Protein bands were
visualized by Coomassie Blue staining before exposure to x-ray film for
the detection of radiolabeled proteins. For two-dimensional
PAGE, soluble parasite and vacuolar proteins from 2 × 109 permeabilized IRBCs were precipitated using 3 volumes
of 10% trichloroacetic acid in acetone containing 20 mM
DTT for 1 h at 20 °C. The proteins were collected by
centrifugation, washed with ice-cold acetone containing 20 mM DTT, and dried. Protein extracts were dissolved in 300 µl of a rehydration solution (8 M urea, 2 M
thiourea, 4%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid, 4%
DTT, 2% ASB (Calbiochem), and 2% immobilized pH gradient buffer pH
4-7 (Amersham Biosciences)) and incubated at room temperature for 1 h. After rehydration for 24 h under low viscosity
paraffin oil, 13-cm immobilized pH gradient strips (Amersham
Biosciences) covering a pH range of 4-7 were subjected to isoelectric
focusing for 28,000 V-h. After isoelectric focusing, the
individual strips were consecutively incubated in equilibration
solution A and B (50 mM Tris-HCl, pH 6.8, 8 M
urea, 30% (v/v) glycerol, 2% (w/v) SDS, complemented with 3.5 mg
ml 1 DTT (solution A) or 45 mg ml 1
iodoacetamide instead of DTT (solution B)), each for 15 min. The
equilibrated strips were transferred to 12% slab gels and separated in
the second dimension. After drying of the gels, radiolabeled bands were
visualized by autoradiography.
Immunoblot Analysis--
Proteins separated by SDS-PAGE or
two-dimensional PAGE were transferred to nitrocellulose membranes. For
the detection of biotin-labeled proteins, membranes were blocked using
2% BSA in PBS, pH 7.4, for 1 h at room temperature. Filters were
incubated for 20 min with alkaline phosphatase-conjugated streptavidin
(Pharmingen) diluted 1:10,000 in 2% BSA in PBS, pH 7.4. The membranes
were washed three times in 10 mM Tris-HCl, pH 7.4, 150 mM NaCl for 5 min. Biotin-labeled proteins were stained
with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolylphosphate
following standard procedures. The same membranes were then incubated
with specific rabbit antisera at a dilution of 1:500 for 16 h at
4 °C. Specific marker proteins were detected after incubation with
horseradish peroxidase-conjugated anti-rabbit IgG for 1 h at room
temperature and development of the filters using the ECL system
(Amersham Biosciences) following standard procedures.
Indirect Immunofluorescence Assay--
Permeabilized and
biotin-treated IRBCs were spread on glass slides and air-dried.
Subsequently, they were fixed in acetone-methanol (1:1) for 10 min at
20 °C. The slides were incubated with the primary antibodies for
2 h at room temperature. The monoclonal anti-band 3 IgG was
diluted 1:20, and the polyclonal rabbit antisera specific for SERP and
aldolase, respectively, were diluted 1:10 in PBS, pH 7.2. After three
washes with PBS, pH 7.2, slides were probed with a mixture of the
corresponding secondary antibody (1:100) and Cy3-conjugated
streptavidin (1:200) for 30 min at room temperature in the dark.
Autofluorescence and nonspecific fluorescence levels were determined by
viewing control samples of either biotin-treated or untreated IRBCs not
incubated with Cy3-conjugated streptavidin and secondary antibodies.
The cells were mounted in glycerol containing 0.1% of the antifade
reagent 1,4-diazobicyclo(2,2,2)-octane. Fluorescence microscopy was
performed using a Leica TCS SP2 laser scanning confocal microscope.
 |
RESULTS AND DISCUSSION |
A Membrane-impermeable Biotin Derivative Gains Access into Intact
Infected Erythrocytes--
The intracellular parasite depends on the
acquisition of nutrients from the extracellular milieu and from the
host cell cytosol. Extracellular nutrients must be taken up across
three membranes, the erythrocyte plasma membrane, the PVM, and the
parasite plasma membrane. In the course of infection, the erythrocyte
plasma membrane undergoes major alterations. Most notably, the
transport properties of the membrane change, increasing the influx
rates for a number of low molecular weight solutes. The identification
of the proteins that mediate these novel transport properties is being
pursued intensely (for current reviews, see Refs. 22-24). In
preliminary experiments designed to study transport of small solutes
across the erythrocyte membrane, we noticed that the
membrane-impermeable sulfo-NHS-SS-biotin gained access to the interior
of erythrocytes infected with trophozoite-stage parasites, but not to
noninfected erythrocytes. Intact noninfected and infected erythrocytes
were incubated with sulfo-NHS-SS-biotin. Cells were lysed in water by
repeated freezing and thawing, and soluble proteins were separated from
the membrane fraction by centrifugation. Whereas in noninfected cells,
no biotin labeling of soluble proteins was detectable (Fig. 1, lanes 1 and 3),
soluble proteins were found to be biotin-labeled in infected cells
(Fig. 1, lanes 5 and 7). When intact erythrocytes were treated with trypsin after the biotin reaction, the pattern of
biotin-labeled proteins in the membrane fraction changed, due to
proteolytic cleavage of externally exposed protein domains (Fig. 1,
lanes 2, 4, 6, and 8). More importantly, trypsin
treatment had little effect on the pattern of biotin-labeled soluble
proteins in infected cells (Fig. 1, lanes 5 and
7). This result demonstrates that the protease, unlike the
biotin derivative, was excluded from the erythrocyte cytosol. Most
likely, access of biotin into intact erythrocytes is due to the novel
transport properties of the erythrocyte membrane, and we are currently
investigating the pathways involved in this process. We never observed
that biotin gained access to vacuolar proteins in infected erythrocytes
using these experimental conditions (data not shown). We anticipate that internalization of biotin across the intact host cell plasma membrane is limited and that the excess of erythrocyte cytosolic proteins prevented efficient labeling of vacuolar proteins.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
Infected erythrocytes are permeable for a
nonpermeant biotin derivative. Noninfected (RBC) and
infected (iRBC) erythrocytes were incubated with
sulfo-NHS-SS-biotin, and a sample from each reaction was subsequently
treated with trypsin (lanes 3, 4, 7, and 8) to
cleave externally exposed proteins. Cells were lysed and separated into
a fraction of soluble proteins (lanes 1, 3, 5, and
7) and into a membrane fraction (lanes 2, 4, 6, and 8). Proteins, corresponding to 2 × 107
cells, were electrophoresed through a 5-15% nonreducing
SDS-polyacrylamide gel, transferred to a nitrocellulose filter, and
probed with alkaline phosphatase-conjugated SAv.
|
|
Biotin Accumulates in the Parasitophorous Vacuole in Permeabilized
Infected Erythrocytes--
Although the vacuolar membrane forms a
barrier between the parasite surface and the host cell cytosol, it is
most conceivable that the PVM allows the transport of nutrients
essential for parasite survival. Using a patch-clamp technique, Desai
et al. (4) measured high conductance channels that are
permeable to organic and inorganic anions and cations. The channels are
open 98% of the time, and they are highly abundant. In bilayers, this
channel allows passage of molecules up to 1,400 Da (5), which is
similar to the nonselective pores discovered in the PVM of the
taxonomically related parasite Toxoplasma (25). The
existence of these pores in Plasmodium-infected erythrocytes
has not been verified biochemically, but if they exist, they should
allow access of membrane-impermeable biotin derivatives that are ~600
Da in size.
To increase access of biotin to the interior of the infected
erythrocyte, we utilized SLO to permeabilize the erythrocyte plasma
membrane. In an initial assessment of our experimental strategy,
infected erythrocytes were permeabilized and, after complete removal of
the erythrocyte cytosol, incubated with the membrane-impermeable
sulfo-NHS-LC-biotin, which was detected using a fluorescent
streptavidin derivative (Fig. 2). The
images show a distinct ring around the periphery of the intracellular
parasite. The biotin co-localizes with the vacuolar marker protein SERP (Fig. 2A). This location is distinct from the location of
the erythrocyte membrane protein band 3 and from the location of the parasite cytosolic protein aldolase (Fig. 2, B and
C). In some parts, the streptavidin and the antibody to band
3 co-localize; this is due to the fact that proteins of the erythrocyte
plasma membrane also react with the biotin. Little if any biotin was detectable in the erythrocyte cytosol and in the parasite cytosol, respectively. A ring-like staining around the periphery of the parasite
can be attributable to a reaction of the biotin with membrane
proteins of the PVM and with soluble vacuolar proteins. Because the
resolution of fluorescence microscopy does not allow discrimination
between a staining of the PVM and a lumenal staining, a more detailed
biochemical analysis was performed to assess the biotinylation of
soluble vacuolar proteins.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 2.
Biotin localizes to the parasitophorous
vacuole. Trophozoite-infected erythrocytes were permeabilized with
SLO, biotin-labeled, and spread onto microscope slides. Cells
were fixed and incubated with antibodies to SERP (A), a
vacuolar resident protein. Conjugated secondary antibodies (green
color) co-localize with SAv-Cy3 (red color).
B and C show dual labeling of biotin and
the erythrocyte membrane protein band 3 (B) or of biotin and
the parasite cytosolic protein PfALD (C). Cells were imaged
using a laser scanning confocal microscope. The left panels
(TM/nomarski) show the transmission images of the respective
fields, and the right panels (merge) show an
overlay of fluorescence images for each of the antibodies used.
|
|
Biotin-labeled Parasite Proteins Bind to SAv-agarose--
Because
mammalian erythrocytes have lost the ability to synthesize proteins
de novo, in infected erythrocytes, radiolabeled amino acids
are incorporated exclusively into parasite proteins. The following
experiment was designed to optimize the biotinylation conditions
and the selective isolation of biotinylated proteins by SAv-agarose.
Infected cells were cultivated for 30 min in the presence of
L-[35S]methionine, and subsequently, the
erythrocyte plasma membrane was permeabilized with SLO to release the
soluble contents of the erythrocyte cytosol. In all experiments, the
integrity of the PVM and the parasite plasma membrane was assessed as
described previously (10). Parasite-containing vacuoles were lysed by repeated freezing and thawing, and the fraction of soluble proteins was
collected after centrifugation. One aliquot of the lysate was treated
with sulfo-NHS-LC-biotin, and another aliquot remained untreated. Both
samples were incubated with SAv-agarose beads, and bound proteins were
eluted by boiling the beads in SDS sample buffer. The fractions of
unbound and bound proteins were analyzed by SDS-PAGE and
autoradiography (Fig. 3A). No
radiolabeled proteins from the nonbiotinylated sample bound to
SAv-agarose (Fig. 3A, lane 2), whereas after biotinylation,
most radiolabeled proteins were found in the fraction of bound proteins
(Fig. 3A, lane 4). It is noteworthy that the pattern of
biotinylated proteins differed from that of the nonbiotinylated
proteins and that the bands appeared less focused. This observation is
attributable to the variant degrees of biotin labeling of individual
polypeptide chains. To assess the effects of biotin incorporation on
the electrophoretic motility of proteins, BSA was incubated with
different molar ratios of sulfo-NHS-LC-biotin and analyzed by SDS-PAGE.
As shown in Fig. 3B, the electrophoretic motility of BSA is
altered depending on the degree of biotinylation.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
A, biotin labeling of parasite proteins.
Infected erythrocytes were metabolically labeled with
L-[35S]methionine. Erythrocytes were
permeabilized with SLO, and the erythrocyte cytosol was extracted. The
remaining fraction consisted of intact parasites, including an intact
PVM and parasite plasma membrane. The PVM and the parasite plasma
membrane were then lysed, and membrane proteins and soluble proteins
were separated. One aliquot of soluble proteins, corresponding to
2 × 108 cells, was treated with sulfo-NHS-LC-biotin
(lanes 3 and 4), and one aliquot remained
untreated (lanes 1 and 2). Proteins that bound to
SAv-agarose beads (lanes 2 and 4) and unbound
proteins (lanes 1 and 3) were analyzed by
SDS-PAGE and autoradiography. B, extensive biotin labeling
increases the molecular size of proteins. BSA was treated with
sulfo-NHS-LC-biotin at different molar ratios and analyzed by SDS-PAGE
and Coomassie Blue staining (lanes 1-3) or by reaction with
peroxidase-conjugated SAv on nitrocellulose filters (lanes
4-6).
|
|
The subsequent experiments were devised to demonstrate
compartment-specific biotinylation of soluble parasite proteins in permeabilized IRBCs. The so-called GBP, the SERP, and parasite aldolase
(PfALD) are soluble marker proteins that are located in different
compartments of the infected erythrocyte. Aldolase is restricted to the
parasite cytosol (19), SERP is restricted to the vacuole (13), and GBP
is found both inside the vacuole and within the erythrocyte cytosol
(10). In the first step, it was confirmed that these proteins can be
biotinylated and that they bind to SAv-agarose, provided that they are
accessible to biotin. This was assessed using lysates of permeabilized
infected erythrocytes; infected erythrocytes were permeabilized with
SLO, and after complete removal of the erythrocyte cytosol, a lysate containing soluble proteins of the parasite cytosol and of the PV was
prepared. One aliquot of soluble proteins was treated with sulfo-NHS-LC-biotin as described above. Another aliquot remained untreated. The samples were incubated with SAv-agarose beads, and the
bound and unbound proteins were analyzed separately by immunoblotting
using antisera to the respective marker proteins (Fig.
4A). In the sample of
nonlabeled proteins, the three marker proteins were recovered in the
fraction of unbound proteins (Fig. 4A, compare lanes
1 and 2). After biotin treatment, GBP, SERP, and PfALD
were recovered in the fraction of bound proteins (Fig. 4A,
compare lanes 3 and 4). In the case of GBP and
SERP, recovery was almost quantitative. Although recovery was not
entirely complete in the case of PfALD, these results demonstrate that
the marker proteins are biotinylated and can be isolated on
SAv-agarose.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
Selective biotin labeling of vacuolar marker
proteins. A, to confirm that the marker proteins can be
biotinylated in solution, a soluble protein fraction was prepared and
processed as described for Fig. 3A. The fraction of proteins
bound to SAv-agarose beads (lanes 1 and 3) and
the fraction of unbound proteins (lanes 2 and 4)
were analyzed by immunoblotting for the presence of the marker proteins
SERP, GBP, and PfALD. B and C, infected
erythrocytes were permeabilized with SLO. After complete extraction of
the erythrocyte cytosol, the cellular fraction consisting of intact
parasites and the intact PV was incubated with sulfo-NHS-LC-biotin and
lysed after removal of free biotin. B, proteins were
immunoprecipitated using antisera against GBP and SERP, respectively,
separated by SDS-PAGE, and transferred to nitrocellulose filters
(lanes 1-4). The filters were first probed with antisera
that were detected in a color reaction using alkaline
phosphatase-conjugated secondary antibodies (lanes 1 and
3). The same filters were reprobed with
peroxidase-conjugated SAv, which was subsequently detected by a
chemiluminescence reaction (lanes 2 and 4). The
incorporation of biotin into aldolase was analyzed in the same way
(lanes 5 and 6), except that soluble proteins
were separated electrophoretically without prior immunoprecipitation.
C, the lysate was reacted with SAv-agarose beads, and the
fractions of bound (lanes 1 and 3) and unbound
(lanes 2 and 4) proteins were analyzed as
described in B for the incorporation of biotin (lanes
1 and 2) and the presence of the respective marker
proteins (lanes 3 and 4).
|
|
After confirmation that all marker proteins are biotinylatable, IRBCs
were permeabilized with SLO, washed to remove the contents of the
erythrocyte cytosol, and incubated with sulfo-NHS-LC-biotin. Upon
removal of free biotin and lysis of parasites, soluble proteins were
immunoprecipitated using antibodies to SERP and GBP, respectively. Precipitated proteins were separated by SDS-PAGE and transferred to
nitrocellulose filters. Initially, the filters were probed with the
SERP and GBP antibodies, and their binding was detected using an
alkaline phosphatase-conjugated secondary antibody (Fig. 4B, lanes 1 and 3). Subsequently, the filters
were reprobed with peroxidase-conjugated SAv and analyzed by
chemiluminescence (Fig. 4B, lanes 2 and 4). The
same analysis was carried out for PfALD, but because the antiserum
against aldolase does not immunoprecipitate the protein, the total
lysate was separated by SDS-PAGE and analyzed (Fig. 4B, lanes
5 and 6). The antisera specifically recognized the
marker proteins. The bands that were detectable with SAv were of
identical sizes as GBP and SERP, indicating that both proteins were
biotin-labeled. No biotin-labeled band corresponding in size to
aldolase was detectable; a protein band of smaller size reacted with
SAv, but not with the aldolase-specific antibody.
Affinity isolation of biotin-labeled proteins on SAv-agarose beads and
subsequent analysis by immunoblotting confirmed the compartment-specific labeling of the respective proteins (Fig. 4C). In permeabilized cells, PfALD was not labeled, and,
consequently, it was not found in the fraction of proteins bound to
SAv, whereas GBP was quantitatively labeled with biotin and recovered.
Apparently, in permeabilized cells, the accessibility of the biotin to
SERP is restricted; all of the biotin-labeled SERP protein is bound to
SAv-agarose beads (Fig. 4C, lanes 1 and 2);
however, a substantial proportion of the SERP molecules remained
unbound, obviously because these molecules have not been labeled with
biotin (Fig. 4C, compare lanes 3 and
4). A 5-fold increase of biotin in the biotinylation reaction did not result in more efficient labeling of SERP (data not
shown). It is noteworthy that in lysates, i.e. when SERP is released, the protein is labeled and binds to SAv quantitatively (Fig.
4A). Although it is possible that the unlabeled protein in
Fig. 4C represents an intraparasite pool of SERP en route to the parasite plasma membrane, we consider this possibility unlikely. In
previous experiments, we were unable to detect levels of SERP within
the parasite, unless secretion was actively inhibited by the drug
brefeldin A (19, 10). It is more likely that, within the vacuole, at
least a proportion of the molecule assumes a tight conformation that
severely compromises the access of biotin. In no experiments did we
detect labeled or unlabeled hemoglobin, the most abundant soluble
protein in trophozoite-infected erythrocytes, indicating that the
soluble erythrocyte contents had been removed efficiently from
permeabilized cells.
The Chaperone PfBiP Associates with Biotin-labeled
Proteins--
Although in none of our experiments using
SLO-permeabilized erythrocytes were we able to detect biotin-labeled
aldolase, we analyzed the fraction of SAv-agarose-bound proteins for
the presence of several other intraparasite proteins. In the fraction
of proteins that were isolated by affinity chromatography on
SAv-agarose beads, we consistently detected PfBiP (26), the plasmodial
homologue of BiP, a molecular chaperone and endoplasmic reticulum
resident protein in eukaryotic cells (Fig.
5A). Because it is possible that some of this protein may not be retained within the parasite's secretory pathway and hence may be transported into the vacuole, we
investigated whether PfBiP was biotin-labeled. Permeabilized cells were
treated with sulfo-NHS-LC-biotin and subsequently lysed, and PfBiP was
immunoprecipitated. The precipitated proteins were separated by
SDS-PAGE and transferred to nitrocellulose filters. In the first
reaction, binding of the anti-PfBiP antiserum was determined using an
alkaline phosphatase-conjugated secondary antibody (Fig. 5B, lane
1). In a second reaction, biotin was detected by chemiluminescence
using peroxidase-conjugated SAv (Fig. 5B, lane 2). Under
these conditions, biotin was undetectable, suggesting that recovery of
PfBiP in the fraction of proteins that bound to SAv-agarose was due to
an interaction of the chaperone with other biotin-labeled proteins.
PfBiP did not bind to SAv-agarose beads in the absence of the biotin
(Fig. 5A), ruling out the possibility that the protein
directly interacted with SAv or the resin. Most likely, when cell
lysates are prepared, intraparasite chaperones such as PfBiP associate
with biotinylated proteins bound to SAv-agarose beads and are
co-isolated. In the subsequent experiments, the protocol was revised to
reduce the possibility of mistaking intraparasite chaperones as
putative vacuolar resident proteins. Chaperones are released from their
substrates in a process that requires the hydrolysis of ATP. Therefore,
SAv-agarose beads were washed in the presence of 5 mM ATP
before electrophoretic analysis. This step eliminated the co-isolation
of PfBiP almost entirely, but it had no effect on the isolation of SERP
(Fig. 5C) or of other biotin-labeled proteins.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
Co-isolation of PfBiP with biotinylated
proteins. A, infected erythrocytes were permeabilized,
and one aliquot of the cells was treated with sulfo-NHS-LC-biotin.
Lysates of cells were prepared and incubated with SAv-agarose beads.
The fraction of unbound proteins (lanes 1 and 3)
and the fraction of bound proteins (lanes 2 and
4) were analyzed for the presence of PfBiP using a specific
antiserum. Lanes 1 and 2, untreated sample;
lanes 3 and 4, biotinylated proteins.
B, PfBip was immunoprecipitated from a sample of
biotin-treated cells, and the precipitate was analyzed by
immunoblotting using either the specific antiserum (lane 1)
or peroxidase-conjugated SAv (lane 2). C,
biotinylated proteins were bound to SAv beads, and the beads were
washed with either HEPES buffer (lanes 1 and 2)
or HEPES buffer containing 5 mM ATP (lanes 3 and
4). Proteins that remained bound to the beads (lanes
2 and 4) and unbound proteins (lanes 1 and
3) were analyzed for the presence of SERP and PfBiP.
|
|
Two-dimensional Gel Electrophoretic Analysis of Biotin-labeled
Parasite Proteins--
As a prerequisite for the identification of
novel vacuolar proteins, IRBCs were labeled metabolically with
L-[35S]methionine, permeabilized with SLO,
and treated with sulfo-NHS-LC-biotin. After cell lysis, soluble
proteins were separated in triplicate on different two-dimensional gels
using a pH gradient of 4-7 in the first dimension. To estimate the
relative abundance of proteins in permeabilized erythrocytes, one gel
was silver-stained (Fig. 6A),
and one gel was stained with Coomassie Blue (Fig. 6B). As expected, silver staining revealed the most complex protein pattern. The most abundant proteins were also detectable using the less sensitive Coomassie Blue stain. To compare biotinylated proteins versus total parasite proteins, proteins of a third gel were
transferred to a nitrocellulose filter. The filter was exposed to x-ray
films to analyze the pattern of radiolabeled proteins (Fig.
6C). Subsequently, biotin-labeled proteins were detected
using alkaline phosphatase-conjugated SAv (Fig. 6D). A
comparison of the biotin-labeled proteins and the radiolabeled proteins
clearly demonstrates that the pattern of biotin-labeled proteins is
less complex and that it does not simply reflect the pattern of the
most abundant radiolabeled proteins. In contrast, the most intensely
radiolabeled proteins appear not to be biotin-labeled. Considering that
cytosolic housekeeping proteins of the parasite, such as enzymes of the
glycolytic pathway, are likely to be highly abundant, this result
underscores the notion that the incorporation of the biotin is
selective. In fact, when a matrix-assisted laser desorption ionization
time-of-flight analysis was carried out using the two most prominent
spots (I and II), they were identified unequivocally as P. falciparum enolase and as P. falciparum ornithine
aminotransferase, respectively (data not shown). Biotin-labeled
proteins form characteristic strings of individual spots. We attribute
this pattern to various degrees of biotin incorporation into the same
polypeptide chain. Because each sulfo-NHS-LC-biotin adds a negative
charge, molecules with a high incorporation of the derivative are
expected to migrate toward the acidic end of the gradient. The shift to
the acidic end of the gradient also correlates with a slight increase
in molecular size. A detailed comparison reveals 12 prominent spots, circled in Fig. 6, A D, which represent highly
abundant parasite proteins that are detectable by Coomassie Blue
staining. Nine of these spots appear negatively stained in Fig.
6D because of the high local concentration of
nonbiotinylated protein. Thirty-nine protein spots were identified that
were both biotinylated and radiolabeled and that therefore fulfill the
criteria expected for vacuolar proteins. Some of these spots may
represent identical polypeptides that are biotinylated to various
degrees. In conclusion, the accessibility of nonpermeant biotin
derivatives to the vacuolar lumen in permeabilized IRBCs has allowed
the identification of candidate vacuolar proteins. These proteins are
restricted in number, and they segregate into a distinct
two-dimensional pattern. The sequencing of the parasite's genome has
almost been completed. This will allow the rapid identification of the
genes encoding vacuolar proteins, as a prerequisite for a molecular
understanding of the cell biological functions of this unusual
compartment in the infected erythrocyte.

View larger version (149K):
[in this window]
[in a new window]
|
Fig. 6.
Protein pattern of putative vacuolar
proteins. Proteins in intact infected erythrocytes were
metabolically labeled, and cells were permeabilized and treated with
biotin. The fraction of soluble proteins, each corresponding to 2 × 109 infected erythrocytes, was subjected to
two-dimensional gel electrophoresis using a pH gradient of 4-7 in the
first dimension and 12% SDS-PAGE in the second dimension.
A, silver-stained gel. B, Coomassie Blue-stained
gel. C and D, proteins from a third
two-dimensional gel were transferred to a nitrocellulose filter. The
filter was first exposed to x-ray film to visualize metabolically
labeled parasite proteins (C) and subsequently reacted with
alkaline phosphatase-conjugated SAv to visualize biotinylated proteins
(D). The most prominent spots that were identified as
parasite proteins are marked with circles. Proteins that are
both biotinylated and radiolabeled are indicated by Arabic
numerals; spots that may represent identical polypeptides at
various degrees of biotinylation are marked with lowercase
letters. I, P. falciparum enolase;
II, P. falciparum ornithine
aminotransferase.
|
|
 |
ACKNOWLEDGEMENT |
We thank U.-G. Maier for critical reading of
the manuscript.
 |
FOOTNOTES |
*
This work was supported by a grant from the Deutsche
Forschungsgemeinschaft.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a scholarship from the German Academic Exchange Service.
Supported by the Alexander von Humboldt Foundation.
**
Present address: Institute of Cell, Animal and Population Biology
(ICAPB), University of Edinburgh, Edinburgh EH9 3JT, Scotland, United Kingdom.

To whom correspondence should be addressed. Tel.:
49-6421-2823404; Fax: 49-6421-2821531; E-mail:
lingelba@mailer.uni-marburg.de.
Published, JBC Papers in Press, August 16, 2002, DOI 10.1074/jbc.M207077200
 |
ABBREVIATIONS |
The abbreviations used are:
PV, parasitophorous
vacuole;
GBP, glycophorin-binding protein;
IRBC, infected red blood
cell;
PfALD, P. falciparum aldolase;
PfBiP, P.
falciparum immunoglobulin heavy chain-binding protein;
PVM, parasitophorous vacuolar membrane;
SAv, streptavidin;
SERP, serine-rich
protein;
SLO, streptolysin O;
PBS, phosphate-buffered saline;
DTT, dithiothreitol;
BSA, bovine serum albumin;
sulfo-NHS-SS-biotin, sulfosuccinimidyl-2-(biotinamido) ethyl-1-3-dithiopropionate;
sulfo-NHS-LC-biotin, sulfosuccinimidyl-6-(biotinamido) hexanoate;
PfEMP1, P. falciparum erythrocyte membrane protein 1.
 |
REFERENCES |
| 1.
|
Pouvelle, B.,
Gormley, J. A.,
and Taraschi, T. F.
(1994)
Mol. Biochem. Parasitol.
66,
83-96[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Ward, G. E.,
Miller, L. H.,
and Dvorak, J. A.
(1993)
J. Cell Sci.
106,
237-248[Abstract]
|
| 3.
|
Dluzewski, A. R.,
Mitchell, G. H.,
Fryer, P. R.,
Griffiths, S.,
Wilson, R. J.,
and Gratzer, W. B.
(1992)
J. Cell Sci.
102,
527-532[Abstract/Free Full Text]
|
| 4.
|
Desai, S. A.,
Krogstad, D. J.,
and McCleskey, E. W.
(1993)
Nature
362,
643-646[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Desai, S. A.,
and Rosenberg, R. L.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2045-2049[Abstract/Free Full Text]
|
| 6.
|
Lingelbach, K.,
and Joiner, K. A.
(1998)
J. Cell Sci.
111,
1467-1475[Abstract]
|
| 7.
|
Bosia, A.,
Ghigo, D.,
Turrini, F.,
Nissani, E.,
Pescarmona, G. P.,
and Ginsburg, H.
(1993)
J. Cell. Physiol.
154,
527-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Wunsch, S.,
Horrocks, P.,
Gekle, M.,
and Lanzer, M.
(1998)
J. Cell Biol.
140,
335-345[Abstract/Free Full Text]
|
| 9.
|
Cooke, B.,
Coppel, R.,
and Wahlgren, M.
(2000)
Parasitol. Today
16,
416-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Ansorge, I.,
Benting, J.,
Bhakdi, S.,
and Lingelbach, K.
(1996)
Biochem. J.
315,
307-314[Medline]
[Order article via Infotrieve]
|
| 11.
|
Wickham, M. E.,
Rug, M.,
Ralph, S. A.,
Klonis, N.,
McFadden, G. I.,
Tilley, L.,
and Cowman, A. F.
(2001)
EMBO J.
20,
5636-5649[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Burghaus, P. A.,
and Lingelbach, K.
(2001)
J. Biol. Chem.
276,
26838-26845[Abstract/Free Full Text]
|
| 13.
|
Knapp, B.,
Hundt, E.,
Nau, U.,
and Küpper, H.
(1989)
Mol. Biochem. Parasitol.
32,
73-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Culvenor, J. G.,
and Crewther, P. E.
(1990)
J. Protozool.
37,
59-65[Medline]
[Order article via Infotrieve]
|
| 15.
|
Cheresh, P.,
Harrison, T.,
Fujioka, H.,
and Haldar, K.
(2002)
J. Biol. Chem.
277,
16265-16277[Abstract/Free Full Text]
|
| 16.
|
Salmon, B. L.,
Oksman, A.,
and Goldberg, D. E.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
271-276[Abstract/Free Full Text]
|
| 17.
|
Guevara Patino, J. A.,
Holder, A. A.,
McBride, J. S.,
and Blackman, M. J.
(1997)
J. Exp. Med.
186,
1689-1699[Abstract/Free Full Text]
|
| 18.
|
Ansorge, I.,
Jeckel, D.,
Wieland, F.,
and Lingelbach, K.
(1995)
Biochem. J.
308,
335-341[Medline]
[Order article via Infotrieve]
|
| 19.
|
Benting, J.,
Mattei, D.,
and Lingelbach, K.
(1994)
Biochem. J.
300,
821-826[Medline]
[Order article via Infotrieve]
|
| 20.
|
Trager, W.,
and Jensen, J. B.
(1976)
Science
193,
673-675[Abstract/Free Full Text]
|
| 21.
|
Pasvol, G.,
Wilson, R. J. M.,
Smalley, M. E.,
and Brown, J.
(1978)
Ann. Trop. Med. Parasitol.
72,
87-88[Medline]
[Order article via Infotrieve]
|
| 22.
|
Kirk, K.
(2001)
Physiol. Rev.
81,
495-537[Abstract/Free Full Text]
|
| 23.
|
Saliba, K. J.,
and Kirk, K.
(2001)
Int. J. Parasitol.
31,
1321-1330[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Krishna, S.,
Webb, R.,
and Woodrow, C.
(2001)
Int. J. Parasitol.
31,
1331-1342[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Schwab, J. C.,
Beckers, C. J. M.,
and Joiner, K. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
509-513[Abstract/Free Full Text]
|
| 26.
|
Kumar, N.,
Koski, G.,
Harada, M.,
Aikawa, M.,
and Zheng, H.
(1991)
Mol. Biochem. Parasitol.
48,
47-58[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Azim-Zadeh, A. Hillebrecht, U. Linne, M. A. Marahiel, G. Klebe, K. Lingelbach, and J. Nyalwidhe
Use of Biotin Derivatives to Probe Conformational Changes in Proteins
J. Biol. Chem.,
July 27, 2007;
282(30):
21609 - 21617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Winter, S. Kawai, M. Haeggstrom, O. Kaneko, A. von Euler, S.-i. Kawazu, D. Palm, V. Fernandez, and M. Wahlgren
SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes
J. Exp. Med.,
June 6, 2005;
201(11):
1853 - 1863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Vincensini, S. Richert, T. Blisnick, A. Van Dorsselaer, E. Leize-Wagner, T. Rabilloud, and C. Braun Breton
Proteomic Analysis Identifies Novel Proteins of the Maurer's Clefts, a Secretory Compartment Delivering Plasmodium falciparum Proteins to the Surface of Its Host Cell
Mol. Cell. Proteomics,
April 1, 2005;
4(4):
582 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|